| Philip J Ayvazian, MD | |
|
25 Oak Avenue, Worcester, MA 01605 | |
| (508) 756-6293 | |
| (508) 756-9404 |
| Full Name | Philip J Ayvazian |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 46 Years |
| Location | 25 Oak Avenue, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487654984 | NPI | - | NPPES |
| 31175338 | Medicaid | MA | |
| 3087255 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 74112 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Harrington Memorial Hospital-1 | Southbridge, MA | Hospital |
| Healthalliance Hospitals, Inc | Leominster, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Worcester Urological Associates Inc | 1456323864 | 3 |
News Archive
A research group led by Takashi Saito, of the Ehime University Graduate School of Medicine, developed a 2-photon excitation light-sheet fluorescence microscope which (1) lowers phototoxicity, (2) extends the field of view, and (3) heightens spatial resolution.
Today's early morning highlights from the major news organizations, including reports about a new "Obamacare" ad in the Arkansas Senate race and a California poll measuring how the state's voters feel about a ballot initiative that would expand the state's ability to regulate health insurance rates.
Tarsa Therapeutics, Inc. today announced progress in the ORACAL trial of its oral calcitonin product for the treatment of postmenopausal osteoporosis. The company has completed patient enrollment in this multinational, randomized, double-blind, placebo-controlled Phase III trial designed to enroll approximately 550 patients. In addition, Tarsa announced that the independent Data Monitoring Committee (DMC) for the ORACAL trial has completed two separate safety reviews of patient data and recommended that the trial proceed as planned.
Medicare's annual open-enrollment season is here and millions of beneficiaries — prompted by a massive advertising campaign and aided by a detailed federal website — will choose a private Medicare Advantage plan.
The anaesthetic drug ketamine has been shown, in low doses, to have a rapid effect on difficult-to-treat depression.
› Verified 8 days ago
| Entity Name | Worcester Urological Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285634782 PECOS PAC ID: 1456323864 Enrollment ID: O20040806000901 |
News Archive
A research group led by Takashi Saito, of the Ehime University Graduate School of Medicine, developed a 2-photon excitation light-sheet fluorescence microscope which (1) lowers phototoxicity, (2) extends the field of view, and (3) heightens spatial resolution.
Today's early morning highlights from the major news organizations, including reports about a new "Obamacare" ad in the Arkansas Senate race and a California poll measuring how the state's voters feel about a ballot initiative that would expand the state's ability to regulate health insurance rates.
Tarsa Therapeutics, Inc. today announced progress in the ORACAL trial of its oral calcitonin product for the treatment of postmenopausal osteoporosis. The company has completed patient enrollment in this multinational, randomized, double-blind, placebo-controlled Phase III trial designed to enroll approximately 550 patients. In addition, Tarsa announced that the independent Data Monitoring Committee (DMC) for the ORACAL trial has completed two separate safety reviews of patient data and recommended that the trial proceed as planned.
Medicare's annual open-enrollment season is here and millions of beneficiaries — prompted by a massive advertising campaign and aided by a detailed federal website — will choose a private Medicare Advantage plan.
The anaesthetic drug ketamine has been shown, in low doses, to have a rapid effect on difficult-to-treat depression.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip J Ayvazian, MD 25 Oak Avenue, Worcester, MA 01605 Ph: (508) 756-6293 | Philip J Ayvazian, MD 25 Oak Avenue, Worcester, MA 01605 Ph: (508) 756-6293 |
News Archive
A research group led by Takashi Saito, of the Ehime University Graduate School of Medicine, developed a 2-photon excitation light-sheet fluorescence microscope which (1) lowers phototoxicity, (2) extends the field of view, and (3) heightens spatial resolution.
Today's early morning highlights from the major news organizations, including reports about a new "Obamacare" ad in the Arkansas Senate race and a California poll measuring how the state's voters feel about a ballot initiative that would expand the state's ability to regulate health insurance rates.
Tarsa Therapeutics, Inc. today announced progress in the ORACAL trial of its oral calcitonin product for the treatment of postmenopausal osteoporosis. The company has completed patient enrollment in this multinational, randomized, double-blind, placebo-controlled Phase III trial designed to enroll approximately 550 patients. In addition, Tarsa announced that the independent Data Monitoring Committee (DMC) for the ORACAL trial has completed two separate safety reviews of patient data and recommended that the trial proceed as planned.
Medicare's annual open-enrollment season is here and millions of beneficiaries — prompted by a massive advertising campaign and aided by a detailed federal website — will choose a private Medicare Advantage plan.
The anaesthetic drug ketamine has been shown, in low doses, to have a rapid effect on difficult-to-treat depression.
› Verified 8 days ago
Mr. Kevan M Sternberg, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 33 Kendall St, Worcester, MA 01605 Phone: 508-334-8765 | |
Timothy B Hopkins, MD Urology Medicare: Medicare Enrolled Practice Location: 25 Oak Avenue, Worcester, MA 01605 Phone: 508-756-6293 Fax: 508-756-9404 | |
Dr. Bhalchandra G Parulkar, MD, MCH Urology Medicare: Accepting Medicare Assignments Practice Location: 85 Prescott Street, Suite 403, Worcester, MA 01605 Phone: 508-753-7259 Fax: 508-753-9577 | |
Dr. Wayne B Glazier, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 85 Prescott St, Suite 403, Worcester, MA 01605 Phone: 508-753-7259 Fax: 508-753-9577 | |
Leonard J. Rampello, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Department Of Urology, Worcester, MA 01655 Phone: 508-856-5821 Fax: 508-856-3137 | |
Jennifer K Yates, Urology Medicare: Accepting Medicare Assignments Practice Location: 33 Kendall St, Department Of Urology, Worcester, MA 01605 Phone: 508-856-5821 Fax: 508-856-3137 |